General ENT News

ENT

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Nikitakis NG et al. - Taken together, these data support the importance of the constitutive Stat3 signaling for growth and survival of salivary gland cancer cells through the induction of survivin. Inhibition of the oncogenic Stat3-survivin pathway in these cells can be achieved by selective targeting techniques or treatment with the NSAID sulindac and holds promise for the treatment of salivary gland cancer.


Today in Salivary Glands...keeping you current

A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer
Cancer, 11/25/09

Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer
Cochrane Reviews, 10/09/09

Clinicopathologic similarities between Mikulicz disease and Kuttner tumor
American Journal of Otolaryngology, 11/04/09